Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Journal of Pathology and Translational Medicine is Scopus-indexed (Q2, CiteScore 3.8), WoS ESCI, DOAJ. Published by Seoul National University.
Checked against the index lists dated .
ISSN 2383-7837Verify ISSN ↗2383-7845Verify ISSN ↗
Publisher: Seoul National University
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pathology and Forensic Medicine | 78 / 209 | 62nd | Q2 |
| Histology | 29 / 62 | 54th | Q2 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2015–present, best quartile Q2, CiteScore 3.8.
Journal of Pathology and Translational Medicine is Q2 in Pathology and Forensic Medicine (rank 78 of 209) and Q2 in Histology (rank 29 of 62), by CiteScore 2025.
Journal of Pathology and Translational Medicine is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 3.8, which places it in quartile Q2 at the 62nd percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.949, quartile Q1, with an H-index of 42.
The publisher lists an article processing charge of about US$175 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Journal of Pathology and Translational Medicine is published by Seoul National University. Its print ISSN is 2383-7837 and its online ISSN is 2383-7845.
Yes — indexed in the Emerging Sources Citation Index.
Yes — it is an open-access journal, listed in DOAJ.
Journal of Pathology and Translational Medicine has an h-index of 51 and a 2-year mean of 2.21 citations per paper (OpenAlex). Its Scopus CiteScore is 3.8, quartile Q2. On 2-year citations it ranks #44 of 208 Scopus journals in Pathology and Forensic Medicine.
Journal of Pathology and Translational Medicine published 50 papers in 2025; its busiest recent year was 2017 with 85. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 99 research articles (2024–2026), authors are most often from South Korea (37.4%), United States (20.3%) and Japan (8.4%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 4 retracted papers are recorded (2.7 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.